LINC01897

Across TCGA pan-cancer cohorts, LINC01897 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated LINC01897 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher LINC01897 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01897 expression acts as an unfavorable survival marker, although some lineages such as LUSC and LAML show a favorable association.

THCA, PCPG, and GBM are the cancer types where LINC01897 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	DFS	Tertile	All	0.444	0.887	<.001	90	view →
PCPG	OS	Tertile	All	0.009	0.946	<.001	36	view →
GBM	OS	Tertile	All	0.086	0.428	<.001	36	view →
SKCM	OS	Tertile	IV	0.244	0.737	<.001	32	view →
LUSC	DFS	Tertile	II,III,IV	1.000	0.589	.014	30	view →
LUAD	OS	Tertile	All	0.612	0.810	.004	27	view →
BLCA	DFS	Tertile	IV	0.169	0.508	.005	21	view →
STAD	DFS	Quartile	All	0.521	0.676	.014	20	view →
CHOL	OS	Tertile	All	0.089	0.673	.018	18	view →
LGG	OS	Tertile	All	0.717	0.894	.006	15	view →
LAML	DFS	Tertile	All	1.000	0.355	.048	12	view →
READ	DFS	Tertile	IV	0.112	0.811	.008	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

LINC01897–THCA (DFS)

Open the THCA breakdown →